HGEN Announces First Patient Dosed at MedStar Washington Hospital Center in Phase 3 Clinical Study of Lenzilumab in COVID-19 | Business Wire P3 ready by Thanksgiving / Mayo Clinic patients discharged in 5 days. See link below??
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.